Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
12/2007
12/06/2007WO2004091503A3 Systems and methods for respiratory event detection
12/06/2007WO2004078141A3 Hemipteran membrane-bound matrix metalloproteinase
12/06/2007WO2004060304A3 Novel compositions and methods in cancer
12/06/2007US20070282105 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility
12/06/2007US20070281939 5-(3,5-Dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(1-hydroxy-cycloheptylmethyl)benzamide derivatives in which the triazine ring has various 4-substituents, e.g., carbamoylmethyl-, dimethylaminoethyl-, acetylaminoethyl-, and pyridinylmethyl-; treating rheumatoid arthritis
12/06/2007US20070281926 Rectal Composition
12/06/2007US20070281328 identifying a test agent as reducing apoptosis of a macrophage cell; reducing the activity of Protein Kinase R
12/06/2007US20070281005 Administering zonisamide; clearing mucus; protective patches
12/06/2007US20070280954 Novel Immunomodulating Peptide
12/05/2007EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1862164A2 Dry powder for inhalation
12/05/2007EP1670415A4 Animal model for protease activity and liver damage
12/05/2007EP1656183B1 Treatment of male sexual dysfunction
12/05/2007EP1148872B1 Stable pharmaceutical formulation comprising pravastatin or atorvastatin
12/05/2007EP1137642B1 Bis-sulfonamides
12/05/2007CN101082058A Method of resolution and racemic mixture of nucleoside enantiomers
12/05/2007CN101081869A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081868A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081867A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN100352443C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
12/05/2007CN100352349C Anhydrous silver dihydrogen citrate compositions
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304063 Inhibitors of Akt activity
11/2007
11/29/2007WO2004066958A3 Caspase-9:bir3 domain of xiap complexes and methods of use
11/29/2007US20070275932 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
11/29/2007US20070275914 Therapeutic Compositions
11/29/2007US20070275911 Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
11/29/2007US20070275902 Treatment of Phosphatidylinositol Phospholipid Disorders
11/29/2007US20070275899 Treatment Of Demyelinating Autoimmune Disease with Modified Ordered Peptides
11/29/2007US20070275881 Oligosaccharide Compositions and Use Thereof in the Treatment of Infection
11/29/2007US20070275368 Posh Associated Kinases And Related Methods
11/29/2007US20070275080 Polymer-Based Microstructures
11/29/2007US20070275003 polynucleotides that code for HPV E6/E7 fusion proteins, having mutagenesis points, used to generate immune responses against HPV and prevent or treat cervical cancer
11/29/2007US20070274997 Compositions and Methods for Herpes Simplex Prophylaxis and Treatment
11/29/2007US20070274989 Methods and Compositions for the Prevention and Treatment of Sepsis
11/29/2007US20070274981 Fibroblast Growth Factor Receptor-1 Inhibitors and Methods of Treatment Thereof
11/29/2007US20070274979 Compositions and Methods for Promoting Neuronal Outgrowth
11/29/2007US20070274910 e.g. 3-[2-(2-Aminophenyl)ethyl]-8-benzyl-7-(2-methylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility
11/28/2007EP1858527A1 Oral dosage forms of gemcitabine derivatives
11/28/2007EP1613263A4 Monitoring and treatment of amyotrophic lateral sclerosis
11/28/2007EP1578399A4 Methods for rapid identification of pathogens in humans and animals
11/28/2007EP1578357A4 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
11/28/2007EP1560571A4 Edible film for relief of cough or symptoms associated with pharyngitis
11/28/2007EP1448201B1 N-(indolcarbonyl-)piperazine derivatives for the treatment of obesity
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/28/2007CN100350919C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/27/2007US7300932 For treatment or prevention of metabolic and cell proliferative diseases; modifying lipid metabolism
11/27/2007US7300676 Astragali seu hedysari radix, Codonposis pilosulae radix, Atractylodes rhizoma, Poria cocos, Raphani semen, Zingiberis siccatun rhizoma, Rehmanniae radix, Gardeniae fructus, Moutan radicis cortex, Glechoma herba, Dioscoreae hypoglauca rhizoma, Lygodii spora, Ostrea tests, Achyranthis radix, etc,
11/27/2007US7300647 Ester derivative of tyrosine; at least one other amino acid compound selected from tryptophan compounds, histidine compounds and lysine compounds; cosmetically acceptable carrier; strength and condition of the hair
11/27/2007US7300473 For dyeing keratin fibres which are capable of giving more intense and yet unselective colorations which show good resistance to the various attacking factors to which the hair may be subjected
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/27/2007CA2292600C Compositions and methods for inhibiting photoaging of skin
11/22/2007WO2005041884A3 Polymer-based microstructures
11/22/2007US20070270456 M3 Muscarinic Acetylcholine Receptor Antagonists
11/22/2007US20070270448 Methods of Using and Compositions Comprising a Jnk Inhibitor for the Treatment and Management of Asbestos-Related Diseases and Disorders
11/22/2007US20070270427 vascular endothelial growth factor receptor inhibitors such as N2-(3-methyl-1H-indazol-6-yl)-N4-{3-[(methylsulfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate, used as anticarcinogenic, antitumor or antiproliferative agents
11/22/2007US20070270404 Tuberculosis treatment using pleuromutilin derivatives
11/22/2007US20070270403 Clozapine and Cocaine Effects on Dopamine and Serotonin Release in Nucleus Accumbens During Psychostimulant Behavior and Withdrawal
11/22/2007US20070270395 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 2-Cyclopropylmethoxy-4-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
11/22/2007US20070270361 Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof
11/22/2007US20070269831 Method for Early Detection of Ovarian Cancer
11/22/2007US20070269790 Methods of Generating Stem Cells and Embryonic Bodies Carrying Disease-Causing Mutations and Methods of Using same for Studying Genetic Disorders
11/22/2007US20070269539 Ginkgo Biloba Extract as a Treatment for Therapeutic-Induced Neurotoxicity
11/22/2007US20070269448 Transition State Analog Inhibitors Of Ricin A-Chain
11/22/2007US20070269420 Compounds, Compositions and Methods for Treatment and Prophylaxis of Hepatitis C Viral Infections and Associated Diseases
11/22/2007US20070269375 Stable Radiopharmaceutical Compositions and Methods for Preparation
11/21/2007EP1857459A2 Pyrazolopyrimidine compound and a process for preparing the same
11/21/2007EP1857101A2 Medicaments
11/21/2007EP1606303A4 Detection and monitoring of lung cancer
11/21/2007CN101076247A Therapeutic immunization of HIV-infected individuals
11/21/2007CN100349904C Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
11/21/2007CN100349882C Method for preparing derivatives of baccatin iii
11/20/2007US7297783 Hsp60 from arthrobacter
11/20/2007US7297714 Inhibitors of cathepsin S
11/20/2007US7297703 Macrolides
11/20/2007US7297701 Anti-cancer cyclopenta [G]quinazoline compounds
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297353 For oral administration, injection and topical application; can eliminate the aseptic inflammations, edema, adhesion caused by aseptic inflammations, and stubborn pain, complex body disorders caused by aseptic inflammation, edema and adhesion
11/20/2007CA2300289C A pharmaceutical composition active in reducing production of mcp-1 protein
11/15/2007WO2005120564A3 Vaccine compositions and methods
11/15/2007WO2005046572A3 Targeted delivery of controlled release polymer systems
11/15/2007WO2005023186A3 Methods of identifying agents that inhibit the growth of cancer cells
11/15/2007WO2004103263A3 Dopamine and agonists and antagonists thereof for treatment of neurodegenerative diseases
11/15/2007WO2004073631A3 Combination therapy for the treatment of neoplasms
11/15/2007WO2003086313A3 Methods for lightening skin and hair
11/15/2007US20070265316 2-(2-Chloro-benzoylamino)-4,5,6,7-tetrahydro-benzo thiophene-3-carboxylic acid amide; increasing activity of mutant-cystic fibrosis transmembrane conductance regulator protein in a cell; increasing halide ion permeability of a cell producing a Delta F508-CFTR protein
11/15/2007US20070265282 Use of ticagrelor treating myocardial infarction, thrombotic stroke, angina and transient ischemic attacks
11/15/2007US20070265199 comprising an A1 domain having a calcium binding site; hemophilia A; antihemophilia agents
11/15/2007US20070264333 Method of treatment
11/15/2007US20070264285 Compositions Comprising Cationic Microparticles And Hcv B1e2 Dna And Methods Of Use Thereof
11/15/2007US20070264280 Compositions and Methods for Treating Neurological Diseases
11/15/2007US20070264267 Nucleotide sequences coding zinc transport protein for use in diagnosis, prevention and treatment of cell proliferative disorders
11/15/2007US20070261178 dyeing keratinous fibers, in particular human keratinous fibers such as hair, comprising, in an appropriate dyeing medium, at least one cationic direct dye of a given formula, and which is characterized in that it contains, in addition, at least one silicone chosen from the aminated silicones and resins
11/14/2007EP1854826A1 Anion-binding polymers and uses thereof
11/14/2007EP1853295A2 Methods and compositions for the treatment of gastrointestinal disorders
11/14/2007EP1565212B1 Gastrin compositions and formulations, and methods of use and preparation
11/14/2007CN101072567A Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one
11/14/2007CN101069744A 流感疫苗组合物 Influenza vaccine composition
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 295